FDA expands approval of Amgen's bone drug Prolia

09/19/2011 | HealthDay News · Boulder County Business Report (Colo.)

The FDA approved Amgen's Prolia to prevent bone fractures in patients with breast or prostate cancer who are undergoing certain hormone therapies. Prolia was originally indicated for postmenopausal women at high risk of osteoporotic fracture.

View Full Article in:

HealthDay News · Boulder County Business Report (Colo.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR